Skip to content

Clinical study to evaluate combined effect of agnilepa and shamanoushadhi in management of Amavata w s r to rheumatoid arthritis

A DOUBLE ARMED OBSERVATIONAL CLINICAL STUDY TO EVALUATE THE COMBINED EFFECT OF AGNI LEPA AND SHAMANA AUSHADIS IN MANAGEMENT OF AMAVATA WSR RHEUMATOID ARTHRITIS - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062207
Enrollment
50
Registered
2024-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

ASWIN HARIDAS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient of either gender ageing 20 TO 70 years in age 2 Diagnosed case of Amavata 3 Patients full filing American association of rheumatology criteria

Exclusion criteria

Exclusion criteria: 1 Patient under other active medical protocols for the same disease 2 With other debilitating co- morbidities 3 Hyper sensitivity to the lepa 4 Having crippling deformity

Design outcomes

Primary

MeasureTime frame
pain reduction by treatmentTimepoint: 21 days follow up

Secondary

MeasureTime frame
improving quality of lifeTimepoint: 28 days

Countries

India

Contacts

Public ContactDR OMPRAKASH DAVE

PARUL INSTITUTE OF AYURVED

omprakash.dave86277@paruluniversity.ac.in9460770626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026